Researchers
Lina Bergman
MD, Specialist Obsterics and Gynecology, PhD
Research:
Prinicipal investigator for neurological complications in PROVE, Principal investigator for GO-PROVE, Co-investigator for IMPACT
Lina is a researcher and clinician, focusing on preeclampsia and organ complications as well as prediction of disease. She is working at Gothenburg University but also affiliated to Uppsala University and Stellenbosch University.
Catherine Cluver
MD, Subspecialist Maternal-Fetal Medicine, Associate Professor
Research:
Principal investigator for PROVE, Principal investigator for PI trials
Catherine is a researcher and clinician, working as a maternal-fetal medicine specialist in Cape Town and leading clinical trials for preeclampsia research at Tygerberg Hospital, Stellenbosch University. She is also affiliated researcher at Mercy Perinatal, Melbourne.
Sonja Schell
Preeclampsia Research Unit Coordinator
Research:
Leads the research midwife team for the PROVE and the Preeclampsia Intervention Trials
Sonja completed a Diploma in general nursing, psychiatry, community health and midwifery followed by a diploma in paediatrics and neonatology.
Anna-Karin Wikström
MD, Specialist Obstetrics and Gynecology, Professor
Research:
Prinicpal investigator for IMPACT, principal investigator for UPMOST, epidemiologist
Anna-Karin is a professor at Uppsala University. She works mainly with preeclampsia research in the fields of epidemiology and observational clinical studies.
Susanne Hesselman
MD, PhD, senior consultant Ob/Gyn Falun Hospital, Sweden
Research:
Epidemiological studies of preeclampsia and labour, affiliated researcher at Uppsala University
Susanne’s research focuses on epidemiological studies of adverse pregnancy outcomes in the Swedish national and quality registers.
Roxanne Hastie
BiomedSc, BSc (Hons), M Epi, PhD, researcher at Mercy Perinatal and affiliated researcher at Uppsala University
Research:
Laboratory based studies and epidemiological studies, Principal investigator for ICE and co-investigator for PROVE
Roxanne is a research scientist dual skilled in complex laboratory and epidemiology research. Roxanne’s research aims to combine these streams to undertake translational research that reduces the burden of major pregnancy complications, including preeclampsia. Roxanne works at the University of Melbourne and Mercy Perinatal and holds an affiliated research position with Uppsala University.
Carlos Escudero Orozco
MD, PhD (Biomedical Sciences), Full-professor Universidad del Bio Bio
Research:
In vitro studies of the vasculature in preeclampsia with material from PROVE, GO PROVE and UPMOST focusing on brain endothelial cells
Carlos Escudero is a vascular physiologist. His current area of interest is to understand the potential negative consequences of preeclampsia in the brain vascular formation and the integrity of the blood-brain barrier in mother and babies exposed to preeclampsia.
Verena Sengpiel
MD, Specialist Obstetrics and Gynecology, Associate Professor
Research:
Co-investigator for GoProve
Verena works as clinician at Sahlgrenska University Hospital and researcher at Gothenburg University.
Isabella Björkman-Burtscher
MD, professor in neuroradiology
Research:
Co-investigator for GO PROVE
Isabella is a professor in Neuroradiology at Sahlgrenska Academy and in charge for the MR protocol in GO PROVE/UPMOST together with Johan Wikström.
Susanne Lager
MSc, PhD, associate professor
Research:
Co-investigator for UPMOST
Susanne Lager is a Senior Lecture in laboratory science at the Department of Women’s and Children’s Health, Uppsala University, Sweden.
Helmuth Reuter
Professor, Head of Division of Clinical Pharmacology, Stellenbosch University
Research:
Pharmacokinetics studies for preeclampsia treatment
Helmuth Reuter is a professor of internal medicine and clinical pharmacology, currently heading the Division of Clinical Pharmacology (at the Faculty of Medicine and Health Sciences) at Stellenbosch University.
Tu’uhevaha Kaitu’u-Lino
BBiomedSci (hons), PhD. Associate Professor at the University of Melbourne
Research:
Laboratory studies to identify new biomarkers for Preeclampsia and to study the pathogenesis of the disease
Tu’uhevaha is head of the Diagnostics Discovery and Reverse Translation Group at the University of Melbourne and Mercy Perinatal.
Eric Decloedt
Associate Professor, Division of Clinical Pharmacology, Stellenbosch University
Research:
Co-investigator for Preeclampsia Intervention trials, Pharmacokinetics studies for preeclampsia treatment
Eric Decloedt is an associate professor and a medical specialist in clinical pharmacology.
Ahmed A. Abulfathi
Senior lecturer and PhD candidate, Division of Clinical Pharmacology, Stellenbosch University
Research:
Pharmacokinetics studies for preeclampsia treatment
Ahmed A. Abulfathi is a Lecturer in the Department of Clinical Pharmacology and Therapeutics, University of Maiduguri, Nigeria, a Clinical Pharmacologist and PhD candidate at Stellenbosch University, South Africa, and Researcher at the Arctic University (UiT), Norway.
Elin Svensson
MSc, PhD, docent at Uppsala university and researcher at Radboud university medical center
Research:
Pharmacometric analysis for preeclampsia studies
Elin Svensson is a pharmacometrician using population pharmacokinetic and pharmacodynamic modeling to understand exposure-response relationships and improve therapies.
Michael A. Belfort
Chairman and Professor, Department of Obstetrics and Gynecology
Research:
Co-investigator for cerebral autoregulation in preeclampsia within PROVE
Professor Belfort is a co-investigator for cerebral autoregulation in preeclampsia within PROVE
Ronney Panerai
Professor
Research:
Participates in the studies of cerebral autoregulation in PROVE, GO PROVE and UPMOST
Professor Panerai is an expert in the field of cerebral autoregulation and participates in the studies of cerebral autoregulation in PROVE, GO PROVE and UPMOST
Teelkien van Veen
MD, PhD
Research:
Co-investigator in PROVE, GO PROVE and UPMOST, focusing on cerebral autoregulation in preeclampsia
Co-investigator in PROVE, GO PROVE and UPMOST, focusing on cerebral autoregulation in preeclampsia
Lilja Thorunn Thorgeirsdottir
RN, RNM, PhD student
Research:
Co-investigator for Go-Prove
Lilja is a midwife at Sahlgrenska University Hospital and a PhD student at Gothenburg University
Eduard Langenegger
MD, PHD. Subspecialist in Maternal Fetal-Medicine and Obstetric Critical Care
Research:
Co-investigator for Prove
Eduard is a clinician and researcher. He established an obstetric critical care unit (OOCU) at Tygerberg Hospital, University of Stellenbosch.
Helen Elden
PhD, Associate professor, RNM
Research:
Co-investigator for GO PROVE
Helen is an associate professor in reproductive and perinatal health and a senior lecturer and the research group leader for the Childbirth research group at the institution of health and care sciences, the Sahlgrenska academy, University of Gothenburg.